Net sales were $0.860 billion for the period, compared to $1.078 billion in the prior year's third quarter. Selling, general and administrative (“SG&A”) expenses were $282.0 million for the period, ...
U.S. stock futures are flat after markets pull back from record highs, GameStop to report earnings after the bell, and Oracle shares dive as its quarterly revenue misses expectations. Here's what ...
Galderma should launch its skin drug Nemluvio, to treat prurigo nodularis in the U.S. and Europe; Ipsen will bring its rare liver disease drug Iqirvo to market; and Sandoz is set to introduce a ...